[REGN] YoY Quarter Result on 30-Sep-2016 [#Q3]

Stock
[REGN] Regeneron Pharmaceuticals, Inc.
Announcement Date
04-Nov-2016
Financial Year
2016
Quarter
30-Sep-2016 [#Q3]
Profit Trend
QoQ- 34.95%
YoY- 25.86%
Quarter Report
REGN's Result
REGN's Financial Summary
View:
Show?
Quarter Result
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Revenue 2,048,400 1,663,496 1,500,673 1,220,122 1,137,422 725,788 597,027 22.79%
PBT 768,500 635,861 565,605 365,881 393,289 176,078 225,684 22.64%
Tax 98,900 41,206 177,288 101,077 182,891 96,358 84,378 2.68%
NP 669,600 594,655 388,317 264,804 210,398 79,720 141,306 29.58%
Tax Rate -12.87% -6.48% -31.34% -27.63% -46.50% -54.72% -37.39% -
Total Cost 1,378,800 1,068,841 1,112,356 955,318 927,024 646,068 455,721 20.25%
Ratio Analysis
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
NP Margin 32.69 35.75 25.88 21.70 18.50 10.98 23.67 5.52%
Per Share
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
EPS 6.12 5.51 3.64 2.53 2.04 0.83 1.44 27.25%
EPS Diluted 5.86 5.17 3.32 2.27 1.82 0.73 1.25 29.35%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.